Epithelial ovarian cancers are associated with a moderately strong genetic susceptibility, with heterozygous carriers of BRCA1 and BRCA2 germline mutations having increased lifetime risk of developing ovarian cancer of 40–60% and 11–30%, respectively [137,138,139]. This evidence concerns the gene BRCA2 and ovarian cancer.